{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:30:02Z","timestamp":1768476602241,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.10.084","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T16:08:01Z","timestamp":1445962081000},"page":"6684-6688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax\u00ae) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013\u20132015"],"prefix":"10.1016","volume":"33","author":[{"given":"Pedro L.","family":"Moro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4912-4621","authenticated-orcid":false,"given":"Scott","family":"Winiecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom T.","family":"Shimabukuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.084_bib0140","unstructured":"Food and Drug Administration. November 20, 2012 Approval Letter \u2013 Flucelvax. Available at: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm328684.htm [accessed 23.03.15]."},{"issue":"June (6)","key":"10.1016\/j.vaccine.2015.10.084_bib0145","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1586\/erv.09.31","article-title":"Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines)","volume":"8","author":"Doroshenko","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"September (RR-07)","key":"10.1016\/j.vaccine.2015.10.084_bib0150","first-page":"1","article-title":"Prevention and Control of Seasonal Influenza with Vaccines: recommendations of the Advisory Committee on Immunization Practices \u2013 United States, 2013\u20132014","volume":"62","author":"Centers for Disease Control Prevention (CDC).","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"August (32)","key":"10.1016\/j.vaccine.2015.10.084_bib0155","first-page":"691","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) \u2013 United States, 2014\u201315 influenza season","volume":"63","author":"Grohskopf","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.10.084_bib0160","unstructured":"Food Drug Administration. Flucelvax, Available at: http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM329134.pdf [accessed 23.03.15]."},{"key":"10.1016\/j.vaccine.2015.10.084_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.084_bib0170","unstructured":"Medical Dictionary for Regulatory Activities. Available at: http:\/\/www.meddramsso.com\/ [accessed 28.04.11]."},{"key":"10.1016\/j.vaccine.2015.10.084_bib0175","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals. http:\/\/www.ich.org\/products\/meddra.html."},{"key":"10.1016\/j.vaccine.2015.10.084_bib0180","first-page":"52252","article-title":"Postmarketing reporting of adverse experiences","volume":"62","author":"Food Drug Administration","year":"1997","journal-title":"Federal Register"},{"key":"10.1016\/j.vaccine.2015.10.084_bib0185","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"R\u00fcggeberg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.084_bib0190","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.084_bib0195","unstructured":"Brighton Collaboration. https:\/\/brightoncollaboration.org\/public."},{"key":"10.1016\/j.vaccine.2015.10.084_bib0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am Stat"},{"key":"10.1016\/j.vaccine.2015.10.084_bib0205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf"},{"issue":"7","key":"10.1016\/j.vaccine.2015.10.084_bib0210","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40264-013-0051-9","article-title":"Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010\u20132011 seasonal influenza virus vaccine","volume":"36","author":"Martin","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2015.10.084_bib0215","unstructured":"European Medicines Agency, Optaflu. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000758\/WC500046957.pdf [accessed 06.04.15]."},{"issue":"June (6)","key":"10.1016\/j.vaccine.2015.10.084_bib0220","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1586\/14760584.2015.1039520","article-title":"Flucelvax (Optaflu) for seasonal influenza","volume":"14","author":"Manini","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.10.084_bib0225","unstructured":"Food Drug Administration. Pharmacovigilance Review Memorandum, August 1, 2912. Office of Biostatistics and Epidemiology\/Division of Epidemiology (OBE\/DE). Pharmacovigilance Plan Review, Influenza vaccine (cell-culture derived trivalent influenza vaccine, cTIV), formerly Optaflu. http:\/\/www.fda.gov\/downloads\/biologicsbloodvaccines\/vaccines\/approvedproducts\/ucm332467.pdf"},{"key":"10.1016\/j.vaccine.2015.10.084_bib0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/aje\/kwp345","article-title":"Near real-time surveillance for influenza vaccine safety: proof-of-concept in the vaccine safety datalink project","volume":"171","author":"Greene","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.10.084_bib0235","series-title":"Adverse effects of vaccines: evidence and causality","first-page":"257","author":"Institute of Medicine Influenza vaccines","year":"2011"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2015.10.084_bib0240","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/cid\/ciu948","article-title":"Allergic reactions after egg-free recombinant influenza vaccine: reports to the US Vaccine Adverse Event Reporting System","volume":"60","author":"Woo","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.084_bib0245","unstructured":"Protein Science Corporation, Flublok package insert. Available at: http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM336020.pdf [accessed 06.04.15]."},{"key":"10.1016\/j.vaccine.2015.10.084_bib0250","unstructured":"Guillain\u2013Barr\u00e9 syndrome and other immune-mediated neuropathies. Chronic inflammatory demyelinating polyneuropathy. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's principles of internal medicine. 18th ed. The McGraw-Hill Companies, Inc.; 2012 [chapter 385]."},{"key":"10.1016\/j.vaccine.2015.10.084_bib0255","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.52.8.1546","article-title":"Assessment: neurologic risk of immunization: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"52","author":"Fenichel","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2015.10.084_bib0260","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1982.03330060038030","article-title":"Guillain\u2013Barr\u00e9 syndrome in the United States, 1979\u201380 and 1980\u201381 \u2013 lack of an association with influenza vaccination","volume":"248","author":"Kaplan","year":"1982","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.vaccine.2015.10.084_bib0265","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain\u2013Barr\u00e9 syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2015.10.084_bib0270","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/cit222","article-title":"Lack of association of Guillain\u2013Barr\u00e9 syndrome with vaccinations","volume":"57","author":"Baxter","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T01:56:14Z","timestamp":1718157374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15015273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":27,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15015273"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.084","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax\u00ae) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013\u20132015","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}